Immucor Inc - GA Gwinnett, Norcross 30071

Immucor Inc entered the industry of Blood Derivative Diagnostic Agents in 2011 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 3254140, which describes it as a Blood Derivative Diagnostic Agents. For further clarification, the SIC classifies this business under the code 2835 and described it as a Blood Derivative Diagnostic Agents. The business provides service to the B2B market.

To acquire more information, please contact William Hawkins, Chief Executive Officer by calling (770) 441-2051 during business hours. You can also write to the business’ Headquarters at 3130 Gateway Drive, Norcross, Georgia GA 30071. You can also visit the company’s website at immucor.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Immucor Inc
Representative: William Hawkins, Chief Executive Officer
Place of Business: 3130 Gateway Drive, Norcross, GA 30071
Contact Number: (770) 441-2051
Website: immucor.com
Type of Service: Blood Derivative Diagnostic Agents
SIC Number: 2835
NAICS Number: 3254140
Locality: Headquarters
Market Type: B2B (Business to Business)
Began: 2011
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

Immucor Inc is a company operating from Gwinnett, Georgia providing professional Blood Derivative Diagnostic Agents and relevant B2B variables. It was founded in 2011 and registered with the SIC code 2835 as Blood Derivative Diagnostic Agents, and with the NAICS code 3254140 as Blood Derivative Diagnostic Agents.

With a current employee count of 1 to 4, Immucor Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative William Hawkins, Chief Executive Officer at (770) 441-2051 for related queries, or to locate its Headquarters using the coordinates 33.93245,-84.25811.

The Headquarters can also be found at the street address 3130 Gateway Drive in Norcross, Georgia 30071 and can be engaged online through the company website at immucor.com, the company Twitter , and Facebook page .